Please login to the form below
stakeholder engagement
This page shows the latest stakeholder engagement news and features for those working in and with pharma, biotech and healthcare.
Gilead Sciences supports Kigali Declaration for neglected tropical diseases
It will also spearhead and contribute to a broad stakeholder dialogue driving pharmaceutical sector engagement and investment in tackling environmental issues causing NTDs, such as climate change and lack of access
Latest news
-
Virtual Science AI introduces new advisory platform
Virtual Science AI has announced the introduction of its Virtual Advisory Artificial Intelligence (AI) engagement platform. ... The organisation uses its AI models and its virtual platform to improve stakeholder engagement in medical affairs, public
-
NICE’s long-serving chief exec Sir Andrew Dillon to step down
However two decades later, the institute is a well-respected body and broadly trusted by the pharma industry and patient organisations, having developed more robust methodologies, transparency and stakeholder engagement.
-
Three agencies join forces to form ONEHealth
sectors. The new business will provide a range of services from R&D support to planning and regulatory strategy, as well as stakeholder engagement to market entry and ongoing communications management. ... She said: “We are incredibly excited to bring
-
Huntsworth reshuffle sees Nitrogen and Tonic join its Evoke Group
Meanwhile, Tonic Life Communications brings global public relations, stakeholder engagement expertise and will strengthen its social media and influencer marketing business to the group.
-
Health Unlimited takes home Innovation award at Communiqué 2016
They explained: “It showed exceptional stakeholder engagement and threw out the rule book to produce a creative and innovative conversation that thought leaders wanted to be part of.
More from news
Approximately 0 fully matching, plus 22 partially matching documents found.
Latest Intelligence
-
The evolution of medical affairs – active cooperation, collaboration and communication
As pharma companies continue to realise the potential positive impact that KOLs can have on their business, KOL engagement will continue to evolve and develop as a critical industry discipline. ... The result? Improved clinical outcomes. Evolving MAF
-
Medical Affairs: centre-stage in scientific engagement strategies
In this era of data overload, a rapidly evolving digital communication landscape and the emergence of hybrid forums for stakeholder engagement, including meetings with Medical Science Liaisons and participation in medical ... congresses, Medical Affairs
-
Product launches: making the most of your one shot
So why does it go wrong so often? There are many potential reasons, including a lack of engagement with key medical and payer stakeholders, an inadequate pricing and market access strategy ... indicators, as well as approaches to stakeholder engagement
-
Strategic launch planning: familiar framework, new mindset
Market engagement: greater local flexibility may be needed in terms of adapting global/ regional strategies. ... To counter these pressures, a more streamlined model is emerging, with tighter core teams driving plan development, supported by targeted
-
Mapping at launch: it’s time to update the satnav
What’s more, that new satnav will help drive better decision-making in everything from resource allocation and stakeholder engagement to omnichannel planning and CX strategy. ... In the launch phase, the data can help inform critical decisions around
More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.
Latest appointments
-
New faces at Lucid Group and ZPB Associates
She also helped the client to navigate complex patient advocacy relations and stakeholder engagement for the launch of the new gene therapy.
-
New faces at 11 London, ramarketing and MSL
With expertise in strategic communications, multi-stakeholder engagement and patient activation, she has supported pharma brands across multiple channels and geographies and been responsible for leading large scale campaigns for clients
-
Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team
Her expertise includes stakeholder engagement, issues and crisis management, media relations and corporate identity.
-
Greg Perry joins IFPMA as assistant director general
At the IFPMA he will have responsibility for its external outreach and stakeholder engagement on global health topics such as innovation, access, and the international regulatory environment.
-
Biogen’s corporate affairs SVP joins Sanofi
She brings over 20 years of policy, advocacy, stakeholder outreach and external engagement experience to the role, most recently from Biogen where she was senior vice president of corporate affairs.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Top 10 Tips for Creating Company Culture in a Virtual World
For many companies, the transition from in-office to remote or flexible work at the beginning of the pandemic may have started off a bit rocky. However, a recent survey from LinkedIn shows that, among Canada’s newly remote workforce, the
-
Top 10 Tips for Running a Successful Virtual Event
As I explored in a recent article previously published on Pharmaphorum, the ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as are the platforms
-
Top 10 Ways that Medical Affairs Team Can Leverage the Impetus Insite Platform
New to asynchronous touchpoints? Don’t know where to start? Need help designing an asynchronous event that will engage your stakeholders and give you the insights you’re looking for? In addition to virtual/hybrid events, there is a multitude of
-
Strategic launch planning: familiar framework, new mindset
Market engagement: greater local flexibility may be needed in terms of adapting global/ regional strategies. ... To counter these pressures, a more streamlined model is emerging, with tighter core teams driving plan development, supported by targeted
-
What does the future hold for Medical Affairs?
journeys. With all this in mind, a new medical affairs communication model is emerging that provides greater collaboration and stakeholder engagement, based on the tailored application of deeper insights. ... As a result, scientific engagement is
More from PMHub
Approximately 5 fully matching, plus 25 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- A new era for UK-Japanese scientific research relations
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
